US OptionsDetailed Quotes

NRXP240517C2000

Watchlist

0.03
0.000.00%

15min DelayClose Mar 22 10:27 ET

0.00High0.00Low

NRX Pharmaceuticals Stock Discussion

TrendTrader

May 20 10:45

Here it comes 👀👀🚀🚀

$NRX Pharmaceuticals(NRXP.US)$

TrendTrader

May 20 10:26

Over 4 can see 4.2 and 4.7

$NRX Pharmaceuticals(NRXP.US)$

Stock_Drift

May 9 14:50

$NRX Pharmaceuticals(NRXP.US)$

NRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to Combat Short Sales

Stock Region

May 7 13:13

Pharmaceutical Company Announces Final Clinical Trial Results For Bipolar Treatment

Encouraged by these results, NRx Pharmaceuticals plans to seek accelerated FDA approval for NRX-101 for patients with bipolar depression at risk of akathisia.
Catching the attention of the pharmaceutical industry and investors alike, NRx Pharmaceuticals (Nasdaq: NRXP), a clinical-stage pharmaceutical company, has announced final clinical trial results showcasing a superior safety profile of NRX-101 over lurasidon...

TrendTrader

May 7 10:21

Solid uptrend today. Over HOD can test yesterday highs

$NRX Pharmaceuticals(NRXP.US)$

TrendTrader

May 6 14:41

If reclaims Vwap can 🚀

$NRX Pharmaceuticals(NRXP.US)$

TrendTrader

May 6 10:58

Scaling in on curl 👀👀

$NRX Pharmaceuticals(NRXP.US)$

TrendTrader

May 6 10:14

Over 3.5 targets are 3.7, 4.12

$NRX Pharmaceuticals(NRXP.US)$

买跌不追涨

May 6 09:20

$NRX Pharmaceuticals(NRXP.US)$ game over

Trytosaveabit

May 6 07:30

News

$NRX Pharmaceuticals(NRXP.US)$ Reuters· just
NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Final Clinical Trial Results: Superior Safety Combined With Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression

No comment yet